Evidence for the participation of cytochrome b5 in hepatic microsomal mixed-function oxidation reactions

https://doi.org/10.1016/0003-9861(71)90186-XGet rights and content

Abstract

The hypothesis is examined that during mixed-function oxidation reactions catalyzed by hepatic microsomes, cytochrome b5 may function by transferring reducing equivalents originating from either DPNH or TPNH to cytochrome P-450, thereby providing one of the two electrons required for cytochrome P-450 function. The conclusion that cytochrome b5 participates in this reaction is based on the observation of a partial reoxidation of reduced cytochrome b5 in the presence of excess DPNH and substrate, when mixed-function oxidation reactions are initiated by the addition of TPNH. The steady-state change of reduced cytochrome b5 is dependent on the presence of oxygen as well as substrate and coincides with product formation and oxygen utilization.

No evidence was obtained for a direct interaction of DPNH with cytochrome P-450 in support of TPNH-dependent hydroxylation reactions. DPNH neither supports TPNH-dependent lipid peroxidation nor has it any stimulating effect upon the anaerobic reduction of cytochrome P-450 in the presence of saturating concentrations of TPNH. Furthermore, it is concluded that the DPNH enhancement of the overall hydroxylation reaction is dependent on the presence of an apparent rate-limiting step in the TPNH-dependent reaction as demonstrated by modifying this step with cations. These observations suggest that cytochrome b5 interacts with a form of cytochrome P-450 in a concerted mechanism at a step after the primary reduction of cytochrome P-450 by reducing equivalents originating from TPNH. The implications of these findings on the apparent rate-limiting step for the overall hydroxylation reaction is discussed.

References (32)

  • M. Waterman et al.

    Biochem. Biophys. Res. Commun

    (1970)
  • S. Orrenius et al.

    Biochem. Biophys. Res. Commun

    (1964)
  • B.S. Cohen et al.

    Arch. Biochem. Biophys

    (1971)
  • B.S. Cohen et al.

    Arch. Biochem. Biophys

    (1971)
  • A.G. Gornall et al.

    J. Biol. Chem

    (1949)
  • S. Orrenius et al.

    Biochem. Biophys. Res. Commun

    (1964)
  • B.K. Tam et al.

    J. Biol. Chem

    (1970)
  • P. Hochstein et al.

    Biochem. Biophys. Res. Commun

    (1963)
  • N. Oshino et al.

    Biochim. Biophys. Acta

    (1966)
  • H.S. Mason

    Advan. Enzymol

    (1957)
  • D.Y. Cooper et al.

    Science

    (1965)
  • R.W. Estabrook et al.
  • V. Ullrich et al.
  • G. Dallner et al.

    J. Cell Biol

    (1966)
  • A. Hildebrandt et al.
  • D.Y. Cooper et al.
  • Cited by (0)

    Supported in part by USPHS Grant 1P11GM-16488.

    2

    Present address: Institut für Klinische Pharmakologie der Freien Universität Berlin, 1 Berlin 45 (Germany), Hindenburgdamm (Klinikum).

    View full text